The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors

Clinical trial NCT05836948 · RECRUITING

Trial details

NCT number: NCT05836948
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-05-18
Primary completion: 2026-05-01
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.